Showing results (1221-1230 of 1,596) with videos related to

Sort By:
Pageof 160
JAMA Psychiatry|March 30, 2017
Changes in US Lifetime Heroin Use and Heroin Use Disorder: Prevalence From the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related ConditionsSilvia S Martins, Aaron Sarvet, Julian Santaella-Tenorio, et al.
JAMA Psychiatry|December 22, 2016
Activation in Bipolar Disorders: A Systematic ReviewJan Scott, Greg Murray, Chantal Henry, et al.
JAMA Psychiatry|December 29, 2016
Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysisAndre R Brunoni, Anna Chaimani, Adriano H Moffa, et al.
JAMA Psychiatry|December 29, 2016
Effects of Contemplative Dyads on Engagement and Perceived Social Connectedness Over 9 Months of Mental Training: A Randomized Clinical TrialBethany E Kok, Tania Singer
JAMA Psychiatry|March 16, 2017
Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysisAbhishekh H Ashok, Yuya Mizuno, Nora D Volkow, et al.
JAMA Psychiatry|April 25, 2014
Overlapping genetic and environmental influences on nonsuicidal self-injury and suicidal ideation: different outcomes, same etiology?Dominique F Maciejewski, Hanneke E Creemers, Michael T Lynskey, et al.
JAMA Psychiatry|March 28, 2014
Mediation of the relationship between callous-unemotional traits and proactive aggression by amygdala response to fear among children with conduct problemsLeah M Lozier, Elise M Cardinale, John W VanMeter, et al.
JAMA Psychiatry|April 18, 2014
Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trialAdriana Feder, Michael K Parides, James W Murrough, et al.
JAMA Psychiatry|April 18, 2014
Atypical cross talk between mentalizing and mirror neuron networks in autism spectrum disorderInna Fishman, Christopher L Keown, Alan J Lincoln, et al.
JAMA Psychiatry|April 4, 2014
Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept studyDaniel Umbricht, Daniela Alberati, Meret Martin-Facklam, et al.
Pageof 160